mumps and rubella vaccine (live)

DRUG4 trials

Sponsors

Rigshospitalet, Gentofte Hospital, Gentofte Hospital, Rijksinstituut voor Volksgezondheid en Milieu (RIVM), Universite Libre de Bruxelles

Conditions

Chronic obstructive pulmonary diseaseHealthy infants receiving a profylactic vaccine to prevent measles infectionMeaslesand rubellamumps

Phase 2

The induction of respiratory immune responses by epicutaneous vaccination with the MMR vaccine

CompletedCTIS2023-503845-79-01

Rigshospitaletand rubella, Measles, mumps

Start: 2024-11-24End: 2025-09-30Target: 40Updated: 2025-11-18

Using live vaccines to induce beneficial innate immune training and reduce systemic inflammation in COPD patients (COPD-LIVE)

CompletedCTIS2023-504519-34-01

Gentofte Hospital, Gentofte HospitalChronic obstructive pulmonary disease

Start: 2024-02-22End: 2025-08-25Target: 60Updated: 2024-04-23

Phase 4

EarLy extra Measles immunisation during a measles Outbreak (ELMO)

Not yet recruitingCTIS2024-513395-18-00

Rijksinstituut voor Volksgezondheid en Milieu (RIVM)Healthy infants receiving a profylactic vaccine to prevent measles infection

Target: 155Updated: 2024-07-22

A single-center, randomized, single-blind, phase 4 study to evaluate the enhancement of mucosal immunity in infants through maternal vaccination during breastfeeding (MEALAC-01).

Not yet recruitingCTIS2025-524862-12-00

Universite Libre de BruxellesMeasles

Target: 120Updated: 2026-04-14